Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancers|September 9, 2023
Beta-Transducin Repeats-Containing Proteins as an Anticancer TargetDong Joon Kim, Yong Weon Yi, Yeon-Sun Seong
Cancers|April 3, 2021
Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer CellsKyu Sic You, Yong Weon Yi, Jeonghee Cho, et al.
Oncogene|March 18, 2025
Therapeutic implication of oxidative stress-induced growth inhibitor 1 (OSGIN1) in cancerDong Joon Kim, Yong Weon Yi, Zigang Dong, et al.
International Journal of Oncology|January 19, 2018
Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cellsKyu Sic You, Yong Weon Yi, Sahng-June Kwak, et al.
Development & Reproduction|August 1, 2020
Ectopic Overexpression of Coiled-Coil Domain Containing 110 Delays G2/M Entry in U2-OS CellsSue Nyoung Lee, Kyeong-Man Hong, Yeon Sun Seong, et al.
International Journal of Biological Macromolecules|June 6, 2025
A review on ribosomal protein S3 (RPS3): Roles in cancer and its resistance to drugsTae-Sung Kim, Yong Weon Yi, Dong Joon Kim, et al.
Anticancer Research|July 1, 2015
Co-treatment with BEZ235 Enhances Sensitivity of BRCA1-negative Breast Cancer Cells to OlaparibYong Weon Yi, Jeong-Soo Park, Sahng-June Kwak, et al.
Cells|January 28, 2026
From Orange to Oncology: Anti-Inflammatory and Anti-Cancer Mechanisms of SinensetinDong Joon Kim, Songyeon Ahn, Xiaomeng Xie, et al.
Oncology Reports|October 14, 2011
ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabineHong-Quan Duong, Hee Jeong Kim, Hyo Jin Kang, et al.
Anticancer Research|March 9, 2012
Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabineYeon Jeong Kim, Jae Seok Hwang, Young Bin Hong, et al.
Pageof 5